Mar 12, 2019 / 08:30PM GMT
Operator
Good afternoon, everyone, and welcome to the Inovio Fourth Quarter 2018 Financial Results Conference Call. (Operator Instructions) Please also note, today's event is being recorded. At this time, I'd like to turn the conference call over to Mr. Ben Matone, Director of Investor Relations. Sir, please go ahead.
Ben Matone - Inovio Pharmaceuticals, Inc. - Director of IR
Thank you, operator. Good afternoon, everyone, and thank you for joining the Inovio Pharmaceuticals Fourth Quarter and Full Year 2018 Corporate Earnings Conference Call. This call is being webcast live on our website, ir. Inovio.com and a replay will be available as indicated in our press release. During this call, we will conduct a question-and-answer segment, which will be reserved for equity research analysts.
Before we begin, I would like to remind everyone that on this call, we will make certain forward-looking statements that relate to our business, which include our plans to develop our DNA immunotherapy platform, in combination with our proprietary delivery devices, developments and
Q4 2018 Inovio Pharmaceuticals Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers